GlaxoSmithKline PLC
02 January 2003
Directors' Interests
I give below details of changes in the directors' interests in the Ordinary
Shares and ADS Shares of GlaxoSmithKline plc.
On 31 December 2002, the following Non-Executive Directors were provisionally
allocated the following awards over Ordinary Shares and American Depository
Shares (ADS's) in the Company through the Annual Re-investment of Dividends paid
throughout 2002, as listed below:
SmithKline Beecham Non-Executive Directors Retainer Fee and Share Allocation
Award - Annual Dividend Reinvestment
Non-Executive Director No. of Average Price (£) No. of ADS's Average Price ($)
Ordinary
Shares
Sir Christopher Hogg 31.485 11.53
Mr P Allaire 14.437 36.73
Mr D McHenry 14.437 36.73
Sir Ian Prosser 31.485 11.53
Dr Lucy Shapiro 51.167 11.53 14.437 36.73
GlaxoSmithKline Non-Executive Directors Automatic Share Award and Elected Share
Award - Annual Dividend Reinvestment
Non-Executive Director No. of Average Price (£) No. of ADS's Average Price ($)
Ordinary
Shares
Sir Christopher Hogg 37.830 11.53
Sir Roger Hurn 178.893 11.53
Mr P Allaire 17.459 36.73
Dr Michele Barzach 37.830 11.53
Sir Peter Job 111.409 11.53
Mr J McArthur 31.871 36.73
Mr D McHenry 17.459 36.73
Sir Ian Prosser 74.619 11.53
Dr Ronaldo Schmitz 73.239 11.53
Dr Lucy Shapiro 17.459 36.73
The Company was notified of this information on 2nd January 2003.
S M Bicknell
Company Secretary
2nd January 2003
This information is provided by RNS
The company news service from the London Stock Exchange DSBTMRTMMIMBFJ
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.